Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test

Environmental and Molecular Mutagenesis

Volumn 41, Issue 1, 2003, Pages 14-27

  Meintières, Sophie ^a   Biola, Armelle ^b   Pallardy, Marc ^b   Marzin, Daniel ^a,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

Author keywords

Apoptosis; bcl2; CTLL 2 cells; Genotoxicity; In vitro micronucleus test

Indexed keywords

ANEUGEN; CLASTOGEN; LIPOCORTIN 5; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; GENOTOXICITY; IN VITRO STUDY; MICRONUCLEUS TEST; MOUSE; NONHUMAN;

EID: 0037261354     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10126     Document Type: Article

References (81)

1. Allen RT, Hunter WJ II, Agrawal DK. 1997. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods 37:215-228.
2. Ames BN, McCann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagene with the Salmonella/mammalian-microsoma mutagenicity test. Mutat Res 31:347-364.
3. Andersson M, Sjostrand J, Petersen A, Honarvar AK, Karlsson JO. 2000. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells. Invest Ophthalmol Vis Sci 41:2623-2632.
4. Azuma Y, Onishi Y, Sato Y, Kizaki H. 1995. Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells. J Biochem (Tokyo) 118:312-318.
5. Beranek DT. 1990. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 231:11-30.
6. Boos G, Stopper H. 2000. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol Lett 116:7-16.
7. Ciesielski M J, Fenstermaker RA. 1999. Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation. J Neurooncol 41:223-234.
8. Cotter TG, Glynn JM, Echeverri F, Green DR. 1992. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res 12:773-779.
9. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G. 2000. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14:729-739.
10. DeMarini DM, Brock KH, Doerr CL, Moore MM. 1987. Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects. Mutat Res 192:151-155.
11. Deng G, Podack ER. 1993. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2- mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 90:2189-2193.
12. Deng G, Podack ER. 1995. Deoxyribonuclease induction in apoptotic cytotoxic T lymphocytes. FASEB J 9:665-669.
13. Duke RC, Cohen JJ. 1986. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5:289-299.
14. Earnshaw WC. 1995. Nuclear changes in apoptosis. Curr Opinion Cell Biol 7:337-343.
15. Elhajouji A, Van Hummelen P, Kirsch-Volders M. 1995. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ Mol Mutagen 26:292-304.
16. Elhajouji A, Tibaldi F, Kirsch-Volders M. 1997. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12:133-140.
17. Elhajouji A, Cunha M, Kirsch-Volders M. 1998. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 13:193-198.
18. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson, PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216.
19. Falcieri E, Martelli AM, Bareggi R, Cataldi A, Cocco L. 1993. The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem Biophys Res Commun 193:19-25.
20. Fenech M, Neville S. 1992. Conversion of excision-repairable DNA lesions to micronuclei within one cell cycle in human lymphocytes. Environ Mol Mutagen 19:27-36.
21. Fenech M. 2000.The in vitro micronucleus technique. Mutat Res 455:81-95.
22. Fritzenschaf H, Kohlpoth M, Rusche B, Schiffmann D. 1993. Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation. Mutat Res 319:47-53.
23. Fujita N, Nagahashi A, Nagashima K, Rokudai S, Tsuruo T. 1998. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene 17:1295-1304.
24. Guo H, Tittle TV, Allen H, Maziarz RT. 1998. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2. Exp Cell Res 245:57-68.
25. Harrington-Brock K, Doerr CL, Moore MM. 1998. Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells. Mutat Res 413:265-276.
26. Higuchi Y, Matsukawa S. 1997. Appearance of 1-2 Mbp giant DNA fragments as an early common response leading to cell death induced by various substances that cause oxidative stress. Free Radic Biol Med 23:90-99.
27. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336.
28. Hoffmann GR. Freemer CS, Parente LA. 1989. Induction of genetic duplications and frameshift mutations in Salmonella typhimurium by acridines and acridine mustards: dependence on covalent binding of the mutagen to DNA. Mol Gen Genet 218:377-383.
29. Hoffman GR, Deschenes SM, Manyin T, Fuchs RP. 1996. Mutagenicity of acridines in a reversion assay based on tetracycline resistance in plasmid pBR322 in Escherichia coli. Mutat Res 351:33-43.
30. Jiang MC, Yang-Yen JF, Yen JJ, Lin JK. 1996. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26:111-120.
31. Jiang MC, Liang HJ, Liao CF, Lu FJ. 1999. Methyl methanesulfonate and hydrogen peroxide differentially regulate p53 accumulation in hepatoblastoma cells. Toxicol Lett 106:201-208.
32. Johnson N, Ng TT, Parkin JM. 1997. Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis. Leuk Res 21:961-972.
33. Kasai T, Ohguchi K, Nakashima S. Ito Y, Naganawa T, Kondo N, Nozawa Y. 1998. Increased activity of oleate-dependent type phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells. J Immunol 161:6469-6474.
34. Khodarev NN, Sokolova IA, Vaughan AT. 1998. Mechanisms of induction of apoptotic DNA fragmentation. Int J Radiat Biol 73:455-467.
35. Kirkland DJ, Marshall RR, McEnaney S, Bidgood J, Rutter A, Mullineux S. 1989. Aroclor-1254 -induced rat-liver S9 causes chromosomal aberrations in CHO cells but not human lymphocytes: a role for active oxygen? Mutat Res 214:115-122.
36. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr. Lorge E, Norppa H, Surralles J, von der Hude W, Wakata A. 2000. Report from the In Vitro Micronucleus Assay Working Group. Environ Mol Mutagen 35:167-172.
37. Krishna G, Kropko ML, Theiss JC. 1989. Use of the cytokinesis-block method for the analysis of micronuclei in V79 Chinese hamster lung cells: results with mitomycin C and cyclophosphamide. Mutat Res 222:63-69.
38. Kroemer G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620.
39. Kumari SR, Alvarez- Gonzalez R. 2000. Expression of c-jun and c-fos in apoptotic cells after DNA damage. Cancer Invest 18:715-721.
40. Kuo ML, Huang TS, Lin JK. 1996. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317:95-100.
41. Lasne C, Gu ZW, Venegas W, Chouroulinkov I. 1984. The in vitro micronucleus assay for detection of cytogenetic effects induced by mutagen-carcinogens: comparison with the in vitro sister-chromatid exchange assay. Mutat Res 130:273-282.
42. Li J, Eastman A. 1995. Apoptosis in an interleukin-2-dependent cytotoxic T lymphocyte cell line is associated with intracellular acidification: role of the Na(+)/H (+)-antiport. J Biol Chem 270:3203-3211.
43. Liu Y, Naumovski L, Hanawalt P. 1997. Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that overexpress BCL2. Cancer Res 57:1650-1653.
44. Luchetti F, Mariani AR, Columbaro M, Di Baldassarre A, Cinti C, Falcieri E. 1999. Apoptotic pathways depend on the target enzymatic activity and not on the triggering agent. Scanning 21:29-35.
45. Lynch AM, Parry JM. 1993. The cytochalasin-B micronucleus/kinetochore assay in vitro: studies with 10 suspected aneugens. Mutat Res 287:71-86.
46. Maron DM, Ames BN. 1983. Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173-215.
47. Matsuoka A, Yamazaki N, Suzuki T, Hayashi M, Sofuni T. 1992. Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat Res 272:223-236.
48. Matsuoka A, Matsuura E, Sakamoto H, Hayashi M, Sofuni T. 1999. A proposal for a simple way to distinguish aneugens from clastogens in the in vitro micronucleus test. Mutagenesis 14:385-389.
49. Mazel S, Burtrum D. Petrie HT. 1996. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 183:2219-2226.
50. McColl KS, He H, Zhong H, Whitacre CM, Berger NA, Distelhorst CW. 1998. Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves Bcl-2 regulated caspase activation. Mol Cell Endocrinol 139:229-238.
51. Meintieres S, Biola A, Pallardy M, Marzin D. 2001. Apoptosis can be a confusing factor in in vitro clastogenic assays. Mutagenesis 16:243-250.
52. Miller BM, Pujadas E, Gocke E. 1995. Evaluation of the micronucleus test in vitro using Chinese hamster cells: results of four chemicals weakly positive in the in vivo micronucleus test. Environ Mol Mutagen 26:240-247.
53. Muscarella DE, Rachlinski MK, Sotiriadis J, Bloom SE. 1998. Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells. Exp Cell Res 238:155-167.
54. Narayan S, Jaiswal AS, Multani AS, Pathak S. 2001. DNA damage-induced cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2. Br J Cancer 85:898-901.
55. Nüsse M, Marx K. 1997. Flow cytometric analysis of micronuclei in cell cultures and human lymphocytes: advantages and disadvantages. Mutat Res 392:109-115.
56. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M. 1993. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679-3684.
57. Ogata S, Okumura K, Taguchi H. 2000. A simple and rapid method for the detection of poly (ADP-ribose) by flow cytometry. Biosci Biotechnol Biochem 64:510-515.
58. O'Reilly LA, Huang DC, Strasser A. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 15:6979-6990.
59. Organization for Economic Cooperation and Development. 1997. OECD guidelines for testing of chemicals: revision of genotoxicity guidelines 471-476, and 483, plus a new guideline 486. Paris: Organization for Economic Cooperation and Development.
60. Parry JM, Parry EM, Boumer R, Doherty A, Ellard S, O'Donovan J, Hoebee B, de Stoppelaar JM, Mohn GR, Onfelt A, Renglin A, Schultz N, Soderpalm-Bemdes C, Jensen KG. Kirsch-Volders M, Elhajouji A, Van Hummelen P, Degrassi F, Antoccia A, Cimini D, lzzo M, Tanzarella C, Adler ID. Kliesch U, Hess O, et al. 1996. The detection and evaluation of aneugenic chemicals. Mutat Res 353:11-46.
61. Perrin-Wolff M, Bertoglio J, Bressac B, Bohuon C, Pallardy M. 1995. Structure-activity relationships in glucocorticoid-induced apoptosis in T lymphocytes. Biochem Pharmacol 50:103-110.
62. Poma A, Zarivi O, Bianchini S, Spano L. 1999. The plant ribosome inactivating protein saporin induces micronucleus formation in peripheral human lymphocytes in vitro. Toxicol Lett 105:67-73.
63. Quash G, Roch AM, Chantepie J, Michal Y, Fournet G, Dumontet C. 1995. Methional derived from 4-methylthio-2-oxobutanoate is a cellular mediator of apoptosis in BAF3 lymphoid cells. Biochem J 305:1017-1025.
64. Rao RV, Hermel E, Castro-Obregon S, del Rio G. Ellerby LM, Ellerby HM, Bredesen DE. 2001. Coupling endoplasmic reticulum stress to the cell death program: mechanism of caspase activation. J Biol Chem 276:33869-33874.
65. Roch AM, Quash G, Michal Y, Chantepie J, Chantegrel B, Deshayes C, Doutheau A, Marvel J. 1996. Altered methional homoeostasis is associated with decreased apoptosis in BAF3 bcl2 murine lymphoid cells. Biochem J 313:973-981.
66. Roch AM, Panaye G, Michal Y, Quash G. 1998. Methional, a cellular metabolite, induces apoptosis preferentially in G2/M-synchronized BAF3 murine lymphoid cells. Cytometry 31:10-19.
67. Schwartz JL. 1989. Monofunctional alkylating agent-induced S-phase-dependent DNA damage. Mutat Res 216:111-118.
68. Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J, Radziszewska E. 1997. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54:899-907.
69. Simko M, Kriehuber R, Weiss DG, Luben AA. 1998. Effects of 50 Hz EMF exposure on micronucleus formation and apoptosis in transformed and nontransformed human cell lines. Bioelectromagnetics 19:85-91.
70. Singh H, Singh JR, Dhillon VS, Bali D, Paul H. 1994. In vitro and in vivo genotoxicity evaluation of hormonal drugs: II, dexamethasone. Mutat Res 308:89-97.
71. Stadheim TA, Kucera GL. 1998. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis. Biochem Biophys Res Commun 245:266-271.
72. Stopper H, Eckert I, Schiffmann D, Spencer DL, Caspary WJ. 1994. Is micronucleus induction by aneugens an early event leading to mutagenesis? Mutagenesis 9:411-416.
73. Van Hummelen P, Kirsch-Volders M. 1992. Analysis of eight known or suspected aneugens by the in vitro human lymphocyte micronucleus test. Mutagenesis 7:447-455.
74. Verhoven B, Schlegel RA, Williamson P. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 182:1597-1601.
75. Vian L, Bichet N, Gouy D. 1993. The in vitro micronucleus test on isolated human lymphocytes. Mutat Res 291:93-102.
76. Vian L, Van Hummelen P, Bichet N, Gouy D, Kirsch-Volders M. 1995. Evaluation of hydroquinone and chloral hydrate on the in vitro micronucleus test on isolated lymphocytes. Mutat Res 334:1-7.
77. Wangenheim J, Bolcsfoldi G. 1988. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis 3:193-205.
78. Warshawsky D, Livingston GK, Fonouni-Fard M, LaDow K. 1995. Induction of micronuclei and sister chromatid exchanges by polycyclic and N-heterocyclic aromatic hydrocarbons in cultured human lymphocytes. Environ Mol Mutagen 26:109-118.
79. Wilson WR, Harris NM, Ferguson LR. 1984. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells. Cancer Res 44:4420-4431.
80. Yamaji T, Nakamura S, Takematsu H, Kawasaki T, Kozutsumi Y. 2001. Apoptosis of CTLL-2 cells induced by an immunosuppressant, ISP-I, is caspase-3-like protease-independent. J Biochem (Tokyo) 129:521-527.
81. Zhang LS, Honma M, Hayashi M, Suzuki T, Matsuoka A, Sofuni T. 1995. A comparative study of TK6 human lymphoblastoid and L5178Y mouse lymphoma cell lines in the in vitro micronucleus test. Mutat Res 347:105-115.